Last updated on August 2019

An Investigational Immuno-therapy Study of Nivolumab Compared to Placebo in Patients With Bladder or Upper Urinary Tract Cancer Following Surgery to Remove the Cancer


Brief description of study

The purpose of this study is to determine the effectiveness and safety of Nivolumab compared to placebo in participants who have undergone radical surgery for invasive urothelial cancer.

Clinical Study Identifier: NCT02632409

Find a site near you

Start Over

California Pacific Medical Center

San Francisco, CA United States
  Connect »

University Of Florida

Gainesville, FL United States
  Connect »

Ft. Wayne Med Onco-Hema Inc

Fort Wayne, IN United States
  Connect »

Tulane University

New Orleans, LA United States
  Connect »

Fairview Health Services

Burnsville, MN United States
  Connect »

Mayo Clinic

Rochester, MN United States
  Connect »

GU Research Network, LLC

Omaha, NE United States
  Connect »

Mount Sinai Medical Center

New York, NY United States
  Connect »

University Of North Carolina

Chapel Hill, NC United States
  Connect »

Lehigh Valley Health Network

Allentown, PA United States
  Connect »

Allegheny General Hospital

Pittsburgh, PA United States
  Connect »

Carolina Urologic Research Center

Myrtle Beach, SC United States
  Connect »

COIBA

Berazategui, Argentina
  Connect »

Hospital Italiano De Buenos Aires

Ciudad Autonoma De Buenos Aire, Argentina
  Connect »

Liverpool Hospital

Liverpool, Australia
  Connect »

Lyell McEwin Hospital

Elizabeth Vale, Australia
  Connect »

Akh Wien

Vienna, Austria
  Connect »

Local Institution

Edmonton, AB Canada
  Connect »

Local Institution

Copenhagen, Denmark
  Connect »

Local Institution

La Roche sur Yon, France
  Connect »

Local Institution

Marseille Cedex 9, France
  Connect »

Local Institution

Heidelberg, Germany
  Connect »

Local Institution

Hirosaki-shi, Japan
  Connect »

Local Institution

Nagasaki-shi, Japan
  Connect »

Local Institution

Higashinari-ku, Japan
  Connect »

Local Institution

Osaka-Sayama-Shi, Japan
  Connect »

Local Institution

Hamamatsu-shi, Japan
  Connect »

Local Institution

Seongnam-si, Korea, Republic of
  Connect »

Local Institution

Seoul, Korea, Republic of
  Connect »

Local Institution

Guadalajara, Mexico
  Connect »

Local Institution

Amsterdam, Netherlands
  Connect »

Local Institution

Maastrict, Netherlands
  Connect »

Local Institution

Nijmegen, Netherlands
  Connect »

Local Institution

Timisoara, Timis, Romania
  Connect »

Local Institution

Moscow, Russian Federation
  Connect »

Local Institution

Saint-Petersburg, Russian Federation
  Connect »

OnkoZentrum Zurich

Zuerich, Switzerland
  Connect »

Local Institution

Cardiff, United Kingdom
  Connect »

Local Institution

London, United Kingdom
  Connect »

Local Institution

Manchester, United Kingdom
  Connect »

Local Institution

Edinburgh, United Kingdom
  Connect »

Local Institution

Sutton, United Kingdom
  Connect »

Cancer Research Centre

Sheffield, United Kingdom
  Connect »

Hospital Britanico De Buenos Aires

Ciudad Autonoma de BuenosAires, Argentina
  Connect »

Theagenio Hospital

Thessaloniki, Greece
  Connect »

Local Institution

Durham, NC United States
  Connect »

Frankston Hospital

Frankston, Australia
  Connect »

Local Institution

Clermont-ferrand, France
  Connect »

Virginia Oncology Associates

Virginia Beach, VA United States
  Connect »

Local Institution

Cerqueira Cesar, Brazil
  Connect »